Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...

Stem Cell Culture

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Machine learning-guided risk stratification for long QT syndrome genetic variants with hiPSC-derived cardiomyocytes.

Cardiovascular research·2026

Same author

MTMR4 variants have opposite gene-specific impact on life-threatening arrhythmic risk in type 1 and 2 long QT syndrome.

European heart journal·2026

Same author

Rate of Participation in a Second Randomized Clinical Trial and Factors Associated with the Likelihood of Participation among IBD Patients who already Experienced a Randomized Clinical Trial.

Crohn's & colitis 360·2025

Same author

Defining minimal criteria for peer-reviewed reporting of mesenchymal stromal cell clinical trials for autoimmune diseases.

Cytotherapy·2025

Same author

Use of hiPSC-derived cardiomyocytes to study LQTS-variant specific proarrhythmic effects of drugs.

Vascular pharmacology·2024

Same author

Electrophysiological effects of estrogen on hiPSC-derived cardiomyocytes of a patient affected by estrogen-sensitive Long-QT Syndrome Type 2.

Vascular pharmacology·2024

Search research articles

Related Experiment Video

Updated: May 23, 2026

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

Mesenchymal stem cell therapy for heart disease.

Massimiliano Gnecchi¹, Patrizia Danieli, Elisabetta Cervio

¹Department of Molecular Medicine, University of Pavia, Viale Golgi 19, 27100 Pavia, Italy. m.gnecchi@unipv.it

Vascular Pharmacology

|April 24, 2012

Summary

Mesenchymal stem cells (MSCs) show promise for cardiac repair by differentiating into heart cells and releasing factors that aid recovery. Clinical trials indicate MSC therapy can improve heart function and reduce damage after injury.

More Related Videos

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells

In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells

Published on: August 9, 2017

Related Experiment Videos

Last Updated: May 23, 2026

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells

In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells

Published on: August 9, 2017

Area of Science:

Regenerative Medicine
Cardiology
Stem Cell Biology

Background:

Mesenchymal stem cells (MSCs) are adult stem cells with self-renewal and multi-lineage differentiation capabilities.
MSCs are found in various tissues, not just bone marrow, and offer therapeutic potential due to easy preparation and immunologic privilege.
Previous studies in animal models of myocardial infarction show MSCs can differentiate into cardiomyocytes and vascular cells.

Purpose of the Study:

To review the current understanding of Mesenchymal stem cell (MSC) biology.
To explore the mechanisms by which MSCs promote cardiac repair.
To highlight the therapeutic potential of MSCs in treating ischemic heart injury.

Main Methods:

Review of existing literature on Mesenchymal stem cell (MSC) biology and function in cardiac repair.
Analysis of preclinical studies in animal models of myocardial infarction.
Examination of data from proof-of-concept and Phase I clinical trials of MSC therapy for cardiac conditions.

Main Results:

Transplanted MSCs can engraft and differentiate into cardiomyocytes and vascular cells in injured hearts.
Engrafted MSCs secrete soluble factors that exert beneficial paracrine effects, contributing significantly to cardiac repair.
MSC therapy has demonstrated improvements in left ventricular function, reverse remodeling, and reduced scar size in clinical trials.

Conclusions:

Mesenchymal stem cells (MSCs) possess properties that can be utilized to prevent and reverse adverse remodeling in the ischemically injured ventricle.
MSC therapy holds significant promise as a therapeutic strategy for cardiac regeneration and repair.
Further understanding of MSC biology and mechanisms of action is crucial for optimizing their clinical application in cardiology.